What is PEG-MGF?
PEG-MGF (PEGylated mechano growth factor) is a polyethylene glycol-modified variant of the IGF-1 splice variant mechano growth factor (MGF), a local isoform of IGF-1 produced in muscles in response to mechanical loading or injury. PEGylation extends the half-life from minutes to approximately 5 days. Research demonstrates activation of muscle satellite cells and promotion of muscle hypertrophy and repair. Research only.
Mechanism of Action
IGF-1 receptor partial agonism via the MGF E-domain; activation and proliferation of muscle satellite (stem) cells (Pax7+); promotes local muscle repair, hypertrophy, and angiogenesis without the systemic IGF-1 metabolic effects
Target: IGF-1 receptor (IGF1R), muscle satellite cells (Pax7+)
Research / educational reference. Educational research index only — not medical advice. Literature maturity is not a verdict on whether a compound works in people. Community reports are not evidence of efficacy.
Evidence at a glance
Derived · maturity-1.0Human efficacy is unproven unless an approved label or completed published efficacy program says otherwise. Counts reflect indexed literature volume/kind — never a verdict on effect.
Literature maturity
nascent 0/100
PubMed hits
0
CT.gov trials
0
Strong-human apps
0
Sample papers
0
Sample articles by era
Application grades (curated)
- Human-grade apps0
- Animal / in-vitro1
- Mechanistic0
Does literature support studied applications?
Grades reflect cited literature posture — not a treatment recommendation. Community notes are never efficacy evidence.
| Application | Cited evidence | Grade | Community |
|---|---|---|---|
| Muscle IGF splice-variant research | MGF/IGF-1Ec biology is largely preclinical; human efficacy for PEG-MGF not established. | Animal / in-vitro | Community reports vary; not evidence of efficacy. |
Pharmacology
Mechanism of action
- •IGF-1 receptor partial agonism via the MGF E-domain; activation and proliferation of muscle satellite (stem) cells (Pax7+); promotes local muscle repair, hypertrophy, and angiogenesis without the systemic IGF-1 metabolic effects
- •Primary target framing: IGF-1 receptor (IGF1R), muscle satellite cells (Pax7+)
Half-life
~5 days (PEGylated form)
Identity & chemistry
Storage & stability
- Lyophilized
- 2–8°C; lyophilized typical shelf 12–18 months
- Reconstituted
- 2–8°C; in-use window often 7–14 days (product-dependent)
- Tell-tale degradation
- !Cloudiness, clumping, or particles after mixing
- !Discoloration versus the expected clear/colorless (or labeled) solution
- !Failed or incomplete reconstitution of lyophilized cake
Educational estimates. Prefer product labeling and peptide shelf-life tool.
Lab handling posture
Research / educational handling notes only. Not a substitute for an SDS.
- •Use PPE appropriate for peptide powder/solution handling
- •Avoid inhalation of lyophilized powder; handle spills per institutional policy
- •Do not present research materials as medicines
Research Indications
Demonstrated acceleration of wound healing and soft tissue repair in research
Research shows beneficial effects on intestinal lining and GI function
Associated with reduced joint inflammation and improved mobility
May support faster recovery from muscle strains and exercise stress
Research Protocols
These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Starting Dose | 100 mcg | Once daily | Subcutaneous injection |
| Standard Dose | 250 mcg | Once daily | Subcutaneous injection |
Peptide & Drug Interactions
Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.
How to Reconstitute & Inject
Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.
- 1
Remove PEG-MGF vial from refrigeration and allow to reach room temperature (15–20 minutes)
- 2
Clean vial top with alcohol swab and allow to air dry completely
- 3
Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)
- 4
Inject BAC water slowly down the side of the vial — do not aim directly at the powder
- 5
Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide
- 6
Allow 2–3 minutes for full dissolution — solution should be clear and colorless
- 7
Draw calculated dose into an insulin syringe for subcutaneous injection
- 8
Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy
- 9
Store reconstituted solution refrigerated (2–8°C) and use within 28 days
What to Expect
Week 1–2
Initial anti-inflammatory effects begin. Reduced pain and swelling in target area.
Week 2–4
Improved tissue mobility and reduced discomfort. Early healing acceleration.
Week 4–8
Significant recovery milestones. Stronger tissue repair and functional improvement.
Week 8–12
Near-complete healing in many cases. Improved strength and tissue integrity.
Side Effects & Safety
- Generally well-tolerated in research settings
- Mild nausea with higher doses
- Injection site redness or discomfort
- Rare: Dizziness or lightheadedness
- Potential effect on blood pressure (monitor if hypertensive)
FDA Status & Regulatory Info
PEG-MGF (PEGylated mechano growth factor) is a polyethylene glycol-modified variant of the IGF-1 splice variant mechano growth factor (MGF), a local isoform of IGF-1 produced in muscles in response to mechanical loading or injury. PEGylation extends the half-life from minutes to approximately 5 days. Research demonstrates activation of muscle satellite cells and promotion of muscle hypertrophy and repair. Research only.
Frequently Asked Questions
Research References
External links for education only. We do not control third-party content.
Community-reported data
The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.
Community Intelligence
What 25 users report
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 97% · Mixed 3% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Self-reported dose per injection
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 200–600 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 87% said they felt similar to their last entry, 13% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 185 days · Based on 23 repeat reporters
Share Your Experience
Rate PEG-MGF in the PeptIQ app and help the community make informed decisions.
Educational information only
This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.